Aug — 2022 MCRA Expands Recently Formed Biocompatibility Division with 2 Key Hires from FDA and Industry Read Article
Jul — 2022 MCRA Assists NeuroMetrix with Obtaining FDA Breakthrough Device Designation and Marketing Authorization in One Year Read Article
Jun — 2022 MCRA and Clients Achieve Significant Milestone - Over 60 Breakthrough Device Designations Granted by FDA Read Article
Jun — 2022 MCRA Assists BONESUPPORT AB with the First Ever Combination Product DeNovo Decision Granted by the U.S. FDA Read Article
Mar — 2022 MCRA Acquires Vorpal Technologies K.K. to Further Expand its Global Advisory Services in Japan Read Article
Jan — 2022 MCRA Assists Active Life Scientific with Clinical Study Execution and Successful De Novo Decision for the OsteoProbe - A New Tool to Measure Bone Tissue Read Article
Jan — 2022 MCRA Assists Multiple Clients with Successfully Obtaining CPT Codes and Hospital Payment Reassignments Read Article
Oct — 2021 MCRA Expands Neurology Division into Medical Robotics, Exoskeletal and Brain Computer Interface Market Read Article